XML 13 R2.htm IDEA: XBRL DOCUMENT v3.23.4
CONSOLIDATED STATEMENTS OF EARNINGS - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Net Sales $ 21,441 $ 20,773 $ 43,312 $ 41,385
Cost of Products Sold 10,144 10,897 20,645 21,743
Selling, General and Administrative Expense 5,522 5,091 11,127 9,918
Impairment of Intangible Assets for Grooming Segment, Indefinite-Lived (Excluding Goodwill) 1,341 0 1,341 0
Operating Income 4,433 4,785 10,200 9,724
Interest Expense (248) (171) (472) (294)
Interest Income 133 66 262 108
Other Non-operating Income/(Loss), Net 177 155 309 294
Earnings/(Loss) from Continuing Operations Before Income Taxes 4,496 4,835 10,299 9,832
Income Taxes on Continuing Operations 1,003 876 2,250 1,910
Net Earnings 3,493 3,959 8,049 7,922
Net Income (Loss) Attributable to Noncontrolling Interest 25 26 60 50
Net Income (Loss) Attributable to Parent $ 3,468 $ 3,933 $ 7,988 $ 7,872
Basic Net Earnings Per Common Share        
Basic Net Earnings/(Loss) Per Common Share [1] $ 1.44 [2] $ 1.63 [2] $ 3.33 $ 3.25
Diluted Net Earnings Per Common Share        
Diluted Net Earnings/(Loss) Per Common Share [1] $ 1.40 [2] $ 1.59 [2] $ 3.23 $ 3.16
[1] Basic net earnings per common share and Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble.
[2] Basic net earnings per common share and Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble.